Case number 1:20-cv-00347
Astellas US LLC et al v. Gland Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 2, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the So Ordered of the Stipulation of Dismissal at D.I. 437 in Lead Case No.18-1675-CFC. (fms) |
| Jun 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-00347-CFC) Stipulation to Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 20-347-CFC and C.A. No. 18-1675-CFC are consolidated for all purposes; All filings shall be made in C.A. No. 18-1675-CFC; Ordered by Judge Colm F. Connolly on 6/18/2020. Associated Cases: 1:20-cv-00347-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Jun 18, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01675-CFC-CJB. ALL FILINGS SHALL BE MADE IN C.A. No. 18-1675-CFC. (fms) |
| Jun 17, 2020 | 14 | Stipulation (6) Docket Text: STIPULATION to Consolidate Action with C.A. No. 18-1675-CFC by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) Modified on 6/17/2020 (fms). |
| May 15, 2020 | 13 | Order (1) Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before June 19, 2020, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 6/19/2020.) Signed by Judge Colm F. Connolly on 5/15/2020. (nmf) |
| May 13, 2020 | 12 | Answer to Counterclaim (10) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim Plaintiffs' Answer to Gland Counterclaims by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Apr 22, 2020 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Defenses, COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Gland Pharma Limited.(Fry, David) |
| Apr 22, 2020 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fosun Pharma Industrial PTE. Ltd, Other Affiliate Fosun Industrial Co., Ltd, Other Affiliate Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Other Affiliate Shanghai Fosun High Technology (Group) Co., Ltd., Other Affiliate Fosun International Ltd., Other Affiliate Fosun Holdings Ltd., Other Affiliate Fosun International Holdings Ltd. for Gland Pharma Limited filed by Gland Pharma Limited. (Fry, David) |
| Apr 17, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Stephen M. Hash, Stephen C. Stout and Emily Pyclik filed by Gland Pharma Limited. Signed by Judge Colm F. Connolly on 4/17/2020. (nmf) |
| Apr 17, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Stephen M. Hash, Stephen C. Stout, Emily Pyclik for Gland Pharma Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Apr 16, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephen M. Hash, Stephen C. Stout and Emily Pyclik - filed by Gland Pharma Limited. (Fry, David) |
| Apr 15, 2020 | 8 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set Of Requests For Production Of Documents And Things To Defendant Gland Pharma Limited filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 25, 2020 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.: For Gland Pharma Limited waiver sent on 3/23/2020, answer due 5/22/2020. (Oakes, Robert) |
| Mar 17, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Gland Pharma Limited on 3/17/2020. (myr) |
| Mar 11, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Mar 10, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
| Mar 9, 2020 | 1 | Exhibit A (22) |
| Mar 9, 2020 | 1 | Exhibit B (22) |
| Mar 9, 2020 | 1 | Exhibit C (20) |
| Mar 9, 2020 | 1 | Exhibit D (18) |
| Mar 9, 2020 | 1 | Civil Cover Sheet (1) |
| Mar 9, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Mar 9, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/25/2020. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 8/25/2022. (nmg) |
| Mar 9, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183; US RE 47,301 E; US 8,524,883. (nmg) |
| Mar 9, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) |
| Mar 9, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (nmg) |
| Mar 9, 2020 | 1 | Complaint* (1) |
